Interstitial lung disease (ILD) complicating connective tissue disorders, such as scleroderma
and rheumatoid arthritis, is associated with significant morbidity and mortality. Progress has …

Interstitial lung disease (ILD) is commonly present in patients with an underlying connective
tissue disease (CTD), particularly those with systemic sclerosis, rheumatoid arthritis, and …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications associated
with connective tissue diseases (CTDs), resulting in significant morbidity and mortality …

Pulmonary complications are an important extra-articular feature of autoimmune rheumatic
diseases and a major cause of mortality. The underlying pathogenesis probably involves …

Interstitial lung disease (ILD) is a challenging clinical entity associated with multiple
connective tissue diseases, and is a significant cause of morbidity and mortality. Effective …

Thoracic involvement, particularly interstitial lung disease (ILD), is common and is an
important contributor to morbidity and mortality in the connective tissue diseases (CTDs) …

The connective tissue diseases (CTDs) are a group of systemic disorders characterized by
autoimmunity and autoimmune-mediated organ damage. The lung is a frequent target and …

Connective tissue disease (CTD) related interstitial lung disease (CTD-ILD) is one of the
leading causes of morbidity and mortality of CTD. Clinically, CTD-ILD is highly heterogenous …

Interstitial lung disease (ILD) is commonly encountered in patients with connective tissue
diseases (CTD). Besides the lung parenchyma, the airways, pulmonary vasculature and …

Introduction: Interstitial lung disease (ILD) is a common manifestation of connective tissue
disease (CTD). Although the majority of patients with CTD-ILD are stable or slowly …